Opposition · USPTO

Opposition 91287371

OtherUSPTO

Opposition 91287371 at USPTO between CTI BioPharma Corp. and Concept to Medicine Biotech Co., Ltd., over the mark CTMBIO, filed Sep 27, 2023. Status in the office record: other.

View CTMBIOGet this data via the API
Status
Other
Result
Other
Filed
Sep 27, 2023
Marks involved
10
Parties

Who is involved

The parties as named in the office record.

Opponent

CTI BioPharma Corp.

Respondent

Concept to Medicine Biotech Co., Ltd.

Timeline

How the case has moved

Dates from the USPTO record and the CTMBIO filing.

  1. CTMBIO filed

    Application 97488777 filed at the USPTO.

  2. Opposition filed

    CTI BioPharma Corp. started opposition 91287371 at USPTO against CTMBIO.
Marks

Marks involved

2 contested marks, 8 marks the challenger relies on.

MarkRoleApplicationOffice
CTMBIOContested97488777USPTO
CTMBIOTECHContested97488860USPTO
CTIRelied on74424879USPTO
CTIRelied on76388984USPTO
CTIRelied on76976598USPTO
CTIRelied on77760445USPTO
CTI BIOPHARMARelied on86282220USPTO
CTI BIOPHARMARelied on86359462USPTO
CTI BIOPHARMARelied on86978798USPTO
CTIRelied on90851461USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

Get API keyView docs
GET /v1/proceedings/{id}
ID=prc_ab64140d-9000-4fb1-a579-dca48ff31c1c
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_ab64140d-9000-4fb1-a579-dca48ff31c1c",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91287371",
  "status": "other",
  "office_code": "US",
  "filed_date": "2023-09-27",
  "parties": [
    {
      "name": "CTI BioPharma Corp.",
      "role": "opponent"
    },
    {
      "name": "Concept to Medicine Biotech Co., Ltd.",
      "role": "respondent"
    }
  ]
}